Stay updated on Nivolumab in AML Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Prevention Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision line on the page was updated from Revision: v3.6.5 to Revision: v3.6.6, reflecting a new release tag on the page.
    Difference
    0.0%
    Check dated 2026-08-29T19:14:22.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The site revision tag was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the platform's underlying frontend framework. This change does not alter clinical content or user-facing study information.
    Difference
    0.0%
    Check dated 2026-08-08T18:54:54.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is displayed on the page, replacing v3.6.3. This indicates a small update to the page's versioning system with no changes to the study data.
    Difference
    0.0%
    Check dated 2026-07-25T11:49:47.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a new page revision in the metadata.
    Difference
    0.0%
    Check dated 2026-07-03T23:56:28.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing v3.6.0, signaling a small update to the page template or backend; no study details or public information were changed.
    Difference
    0.0%
    Check dated 2026-06-27T00:25:59.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now states 'No longer looking for participants', indicating the REMAIN trial is not currently enrolling. This reflects a shift in recruitment status for the AML maintenance study and affects potential participants' ability to join.
    Difference
    0.3%
    Check dated 2026-06-12T14:48:14.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.